Literature DB >> 6441188

Measurement of prostaglandin D2 and identification of metabolites in human plasma during intravenous infusion.

S E Barrow, D J Heavey, M Ennis, C G Chappell, I A Blair, C T Dollery.   

Abstract

A stable isotope dilution assay has been developed for the quantification of prostaglandin D2 (PGD2) in plasma. Samples are analysed by capillary column gas chromatography/negative ion chemical ionisation mass spectrometry (GC/NICIMS). The method employs an internal standard of [2H6]PGD2, prepared biosynthetically by incubation of rat peritoneal mast cells with deuterated arachidonic acid. No PGD2 was detected in peripheral venous plasma samples obtained from 10 healthy male volunteers (detection limit = 5 pg ml-1). Following intravenous infusion of PGD2 at increasing incremental infusion rates ranging from 16-256 ng kg-1 min-1, a dose related increase in the plasma concentration of PGD2 was observed. Plasma levels at 128 ng kg-1 min-1 ranged from 724-1444 pg ml-1. The major circulating metabolites of PGD2, during infusion, were identified as 13,14-dihydro-15-oxo-PGF2 alpha and 15-oxo-PGF2 alpha.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6441188     DOI: 10.1016/0090-6980(84)90032-7

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  5 in total

1.  The release of prostaglandin D2 from human skin in vivo and in vitro during immediate allergic reactions.

Authors:  R M Barr; O Koro; D M Francis; A K Black; T Numata; M W Greaves
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

2.  High-throughput quantification of bioactive lipids by MALDI mass spectrometry: application to prostaglandins.

Authors:  Joseph D Manna; Michelle L Reyzer; Joey C Latham; C David Weaver; Lawrence J Marnett; Richard M Caprioli
Journal:  Anal Chem       Date:  2011-08-01       Impact factor: 6.986

3.  Identification of 13,14-dihydro-15-oxo-prostaglandin F2 alpha in the circulation during infusions of bradykinin and prostaglandin E2 in man.

Authors:  S E Barrow; J Cockcroft; C T Dollery; N E Hickling; J M Ritter
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

4.  Evidence against the formation of 13,14-dihydro-15-keto-prostaglandin F2 alpha following inhalation of prostaglandin D2 in man.

Authors:  C C Hardy; S T Holgate; C Robinson
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

5.  Targeted Lipidomics for Characterization of PUFAs and Eicosanoids in Extracellular Vesicles.

Authors:  Madlen Reinicke; Saikal Shamkeeva; Max Hell; Berend Isermann; Uta Ceglarek; Mitja L Heinemann
Journal:  Nutrients       Date:  2022-03-22       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.